Company intelligence / Profile preview

Joint Science

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Joint Science (Beijing) Biotechnology Co., Ltd. is a Chinese medical technology company focused on the development and manufacturing of in vitro diagnostic (IVD) products. Established in 2011, the company specializes in Point-of-Care Testing (POCT) solutions, utilizing fluorescence immunochromatography and other advanced diagnostic technologies. Its portfolio includes a range of diagnostic kits for cardiac markers, inflammatory indicators, and infectious diseases, alongside automated analyzers like the JS-1000 and JS-2100. Joint Science serves clinical laboratories and healthcare providers globally, providing rapid and reliable diagnostic tools to improve patient care.

Therapeutic areas: CardiovascularEndocrinologyInfectious DiseasesNephrologyImmunology
Modalities: In vitro diagnosticsPOCT
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Joint Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joint Science.

Explore the full profile